A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2009
08/19/2009	EP2089053A1 Hpv antigen fusion protein vaccine compositions and uses thereof
08/19/2009	EP2089052A1 Peg linker compounds and biologically active conjugates thereof
08/19/2009	EP2089051A2 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
08/19/2009	EP2089045A2 Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia
08/19/2009	EP2089029A2 Pak modulators
08/19/2009	EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof
08/19/2009	EP1482973B1 Methods of modulating cd200 receptors
08/19/2009	EP1463529B1 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy
08/19/2009	EP1339425B1 Vaccine composition containing transforming growth factor alpha
08/19/2009	EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
08/19/2009	EP1187918B9 Tek antagonists
08/19/2009	EP1175226B1 Lipoglycan compositions and methods of treating parasitic infections
08/19/2009	EP1131424B1 Mutation of the parkin gene, compositions, methods and uses
08/19/2009	EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis
08/19/2009	EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses
08/19/2009	EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
08/19/2009	CN101512007A Methods and compositions for use in treatment of patients with autoantibody positive diseases
08/19/2009	CN101512000A Process for making oligopeptides
08/19/2009	CN101511871A Anti-myostatin antibodies
08/19/2009	CN101511870A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
08/19/2009	CN101511869A Anti-MCP-1 antibodies, compositions, methods and uses
08/19/2009	CN101511387A Arginine wash in protein purification using affinity chromatography
08/19/2009	CN101511386A Methods of treating brain tumors with antibodies
08/19/2009	CN101511385A Making influenza virus vaccines without using eggs
08/19/2009	CN101511384A Dendritic cells generated using GM-CSF and interferon alpha and loaded with heat-treated and killed cancer cells
08/19/2009	CN101509009A Amalgamation gene of hepatitis B virus L gene and Ag85B, construction and uses of its expression vector
08/19/2009	CN101509008A Amalgamation gene of hepatitis B virus L gene and hGM-CSF, construction and uses of its expression vector
08/19/2009	CN101509003A Sequence of enterovirns type71 genome and uses thereof
08/19/2009	CN101509002A Recombinant rubella virus protein and uses thereof
08/19/2009	CN101508999A Recombinant toxoplasma protein and uses thereof
08/19/2009	CN101508978A Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
08/19/2009	CN101508977A Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
08/19/2009	CN101508734A Anti-CD40 monoclonal antibody
08/19/2009	CN101508733A Human avian influenza specific immunity globulin and preparation thereof
08/19/2009	CN101508721A Limited simulation CTL epitope of tumor antigen Ran HLA-A*0201 and uses thereof
08/19/2009	CN101507816A Riemerlla anatipestifer bivalent inactivated vaccine and preparation method thereof
08/19/2009	CN101507815A Vibrio harveyi recombined outer-membrane protein Ompk microspheres vaccine and preparation method thereof
08/19/2009	CN101507814A Multi-component antigen acellular pertussis vaccine and preparation method thereof
08/19/2009	CN101507813A Technique for removing meningococcus polysaccharide endotoxin
08/19/2009	CN101507812A Aluminum adjuvant dry-power vaccine and preparation method thereof
08/19/2009	CN100529076C Mammalian cytokines, related reagents and methods
08/19/2009	CN100529075C Antihuman telomere enzyme reverse transcriptase single-chain antibody
08/19/2009	CN100529074C Therapeutic binding molecules
08/19/2009	CN100529054C Modulating production of pneumococcal capsular polysaccharide
08/19/2009	CN100528896C Chimeric antigen for preventing, diagnozing and treating respiratory syncytial virus infection and its antibody
08/19/2009	CN100528240C Preparation method and medicinal uses of Trichinella eelworm vaccine
08/19/2009	CN100528238C Oral DNA combination for treating chronic infection of hepatitis B virus
08/19/2009	CN100528230C Recombination human MUC1-MBP fusion protein antitumour vaccine and production technology
08/19/2009	CN100528229C Method of inhibiting tumor growth with anti-tissue factor antibodies
08/19/2009	CN100528228C Escape mutants of newcastle disease virus as marker vaccines
08/19/2009	CN100528227C Vaccine for virus of encephalitis B and preparation method
08/19/2009	CN100528226C Virus-like particles of human papillomavirus
08/19/2009	CN100528225C Methods for the in vitro culture of sporozoea species and uses thereof
08/18/2009	US7576258 Transgenic transchromosomal rodents for making human antibodies
08/18/2009	US7576194 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection; for immunodiagnosis and immunoprophylaxis
08/18/2009	US7576189 antibodies against such VEGFs, which may be used to inhibit their action, for example, to inhibit the growth of tumors, to treat diabetic retinopathy, rheumatoid arthritis and psoriasis
08/18/2009	US7576188 Antitumoral treatments
08/18/2009	US7576185 PRO34128 antibodies
08/18/2009	US7576184 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity
08/18/2009	US7576183 Structure-based receptor MIMICS targeted against bacterial superantigen toxins
08/18/2009	US7576182 Compositions and methods for the treatment of immune related diseases
08/18/2009	US7576179 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
08/18/2009	US7576176 Neisseria meningitidis antigens and compositions
08/18/2009	US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/18/2009	US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption
08/18/2009	US7576066 Administering nucleic acid to stimunlate immunology response
08/18/2009	US7576058 Method for importing biologically active molecules into cells
08/18/2009	US7576056 Peptides and compounds that bind to a receptor
08/18/2009	US7576054 Administering a synergistic mixture containsing 6% nisin and 2% mupirocin for killing/inhibiting growth of Staphylococcus aureus
08/18/2009	US7575929 Diagnosis of multiple sclerosis with diketopiperazines
08/18/2009	US7575923 CD19xCD3 specific polypeptides and uses thereof
08/18/2009	US7575916 Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid molecule
08/18/2009	US7575880 Method of screening an antibody for activity in clearing an amyloid deposit
08/18/2009	US7575877 Method of diagnosing tuberculosis
08/18/2009	US7575873 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis
08/18/2009	US7575870 Assay method for peptide specific T-cells
08/18/2009	US7575755 Method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as "GPI") inositolglycan domain or its derivative or equivalent
08/18/2009	US7575754 Genetic engineered mutant against Escherichia; veterinary medicine
08/18/2009	US7575753 Relates to a kit for detecting and distinguishing one or more small round structure viruses (hereinafter called "SRSVs") in a specimen; SRSV detection kit comprising all antibodies against SRSV-related virus constituting peptides; human viral gastroenteritis
08/18/2009	US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome
08/18/2009	US7575751 Activin-A mutants
08/18/2009	US7575750 Antifusogenic; antiviral conjugates; point mutations
08/18/2009	US7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/18/2009	US7575748 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
08/18/2009	US7575747 Antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarity determining regions derived from murine antibody 266; useful for treatment or prevention of conditions associated with A beta, including Alzheimer's disease, Down's syndrome
08/18/2009	US7575746 anticarcinogenic; antibody or antigen-binding portion that specifically binds to human insulin-like growth factor I receptor; comprises: light and heavy chain region with frameworks mutations reverted back to amino acid sequence encoded by germ line A30 and DP35 genes; genetic engineering
08/18/2009	US7575745 Ligand for herpes simplex virus entry mediator and methods of use
08/18/2009	US7575742 Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist
08/18/2009	US7575741 Using interleukin-23 modulators to enhance wound healing
08/18/2009	CA2388731C Pharmaceutical products and methods of fabrication therefor
08/18/2009	CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/18/2009	CA2223691C Tumor- or cell-specific herpes simplex virus replication
08/18/2009	CA2165203C Immunoglobulin g concentrate for therapeutic use and method for producing same
08/18/2009	CA2105552C Soluble ligands for cd40
08/18/2009	CA2054798C Hcv-specific peptides, agents therefor and the use thereof
08/13/2009	WO2009100422A2 Drug delivery system comprising microparticles and gelation system
08/13/2009	WO2009100376A2 Modification of antigens while maintaining antibody binding epitopes
08/13/2009	WO2009100318A1 1b20 pcsk9 antagonists
08/13/2009	WO2009100297A1 1d05 pcsk9 antagonists
08/13/2009	WO2009100194A2 Camptothecin-binding moiety conjugates

1 ... 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 ... 1823